HAGAN JOSEPH P (President and CEO) sold 37.6% of their position (127.05K shares) of REGULUS THERAPEUTICS INC. on the open market
Open‑market sale worth $160.5K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/15/2025ACC: 0000950170-25-005883
DirectorOfficer· President and CEO
Since Feb 2019
-127.05K
Net shares
Net seller
$160.5K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
127.05K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−115.29K
Price / share
$1.26
Trade value
$145.63K
% of position
34.1%
1/13/2025
337.86K→222.57K
Common Stock
Direct
Shares
−11.76K
Price / share
$1.26
Trade value
$14.86K
% of position
5.3%
1/14/2025
222.57K→210.81K
Total
Net shares
−127.05K
Net value
-$160.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/13/2025 | S · Sale | −115.29K | $1.26 | $145.63K | 34.1% | 337.86K | 222.57K |
| Common Stock Direct | 1/14/2025 | S · Sale | −11.76K | $1.26 | $14.86K | 5.3% | 222.57K | 210.81K |
| Total | −127.05K | -$160.49K | ||||||
Derivative Transactions0
No derivative transactions reported